| Literature DB >> 31897185 |
Lan Luo1, Qian Luo2, Liang Tang3.
Abstract
Diagnostic value and clinical significance of magnetic resonance imaging (MRI) and computed tomography (CT) in detecting lymph node metastasis of early cervical cancer were investigated. From April 2015 to April 2019, 160 patients with lymph node metastasis (stage I-II) of early cervical cancer in Jining No. 1 People's Hospital were retrospectively analyzed. All the patients underwent MRI, CT diagnosis and MRI combined with CT diagnosis before operation. Sensitivity, specificity and diagnostic accordance rate, the diagnostic value and clinical significance of MRI, CT and MRI combined with CT in the diagnosis of lymph node metastasis of early cervical cancer were compared. The sensitivity, specificity and diagnostic accordance rate of MRI in the diagnosis of lymph node metastasis of early cervical cancer in stage Ia-Ib were 75.00, 72.92 and 77.50%, respectively, which were significantly higher than those of PET/CT in the same period (P<0.05). The sensitivity, specificity and diagnostic accordance rate of MRI combined with CT in the diagnosis of early cervical cancer in stage Ia-Ib were 78.13, 87.50 and 83.75%, respectively, which were significantly higher than those of MRI or CT alone (P<0.05). However, the sensitivity, specificity and diagnostic accordance rate of MRI combined with CT in the diagnosis of lymph node metastasis of early cervical cancer in stage IIa-IIb were 91.66, 82.81 and 88.13%, respectively, which were significantly higher than those of MRI or CT alone (P<0.05). MRI is superior to CT in the diagnosis of lymph node metastasis of early cervical cancer. However, the diagnostic efficiency of combined scans of the two is far higher than that of MRI or CT alone, which has more diagnostic value. In clinic, MRI and CT should be combined to improve the diagnostic accuracy of diseases. Copyright: © Luo et al.Entities:
Keywords: CT; MRI; early cervical cancer; lymph node metastasis
Year: 2019 PMID: 31897185 PMCID: PMC6924181 DOI: 10.3892/ol.2019.11180
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967
Features of MRI of early cervical cancer in different stages.
| Grouping | Features |
|---|---|
| Stage Ia | No evidence of mass lesion. |
| Stage Ib | Tumor pierced cervical low signal intensity ring. |
| Stage IIa | The tumor pierced the upper vagina but did not touch the parametrium. |
| Stage IIb | The matrix of the cervix was destroyed and the parametrium tissues were invaded. |
MRI, magnetic resonance imaging.
Features of CT of early cervical cancer in different stages.
| Grouping | Features |
|---|---|
| Stage Ia | No metastatic lymph nodes. |
| Stage Ib | Metastatic lymph nodes appeared, but were not obvious. |
| Stage IIa | Metastatic lymph nodes appeared but did not invade the parametrium. |
| Stage IIb | Metastatic lymph nodes began to invade the parametrium. |
CT, computed tomography.
Figure 1.Number of early cervical cancer patients tested with four different stages.
Baseline clinical data of 160 SC patients.
| Factors | [n(%)] |
|---|---|
| Age (years) | |
| ≤50 | 105 (65.63) |
| >50 | 55 (34.37) |
| Smoking | |
| Yes | 81 (50.63) |
| No | 79 (49.67) |
| Drinking | |
| Yes | 78 (48.75) |
| No | 82 (51.25) |
| Obesity | |
| Yes | 80 (50.00) |
| No | 80 (50.00) |
| Histological classification of cervical cancer | |
| Squamous cell carcinoma | 122 (76.25) |
| Adenosquamous carcinoma | 18 (11.25) |
| Endometrioid adenocarcinoma | 10 (6.25) |
| Clear cell carcinoma | 10 (6.25) |
| Clinical stage of cervical cancer | |
| Stage Ia | 17 (10.63) |
| Stage Ib | 47 (29.37) |
| Stage IIa | 43 (26.87) |
| Stage IIb | 53 (33.13) |
| Differentiation degree | |
| Poorly differentiated | 65 (40.63) |
| Middle differentiated | 45 (28.12) |
| Well differentiated | 50 (31.25) |
| Lymph node metastasis | |
| Yes | 96 (60.00) |
| No | 64 (40.00) |
Figure 2.Differentiation of tumors.
Diagnostic efficacy of MRI in lymph node metastasis of early cervical cancer in stage I.
| Pathological diagnostic results | |||
|---|---|---|---|
| Grouping | Stage Ia-Ib | Stage non-Ia-Ib | Total |
| Ia-Ib phase by MRI diagnosis | 54 | 26 | 80 |
| Non-Ia-Ib phase by MRI diagnosis | 10 | 70 | 80 |
| Total | 64 | 96 | 160 |
MRI, magnetic resonance imaging.
Comparison of diagnostic efficiency of MRI and CT in lymphatic metastasis of early cervical cancer in stage I.
| Factors | MRI | CT | χ2 value | P-value |
|---|---|---|---|---|
| Sensitivity | 75.00% (54/64) | 62.50% (40/64) | 7.850 | 0.005 |
| Specificity | 72.92% (70/96) | 56.25% (54/96) | 5.829 | 0.016 |
| Diagnostic accordance rate | 77.50% (124/160) | 58.75% (94/160) | 12.950 | <0.001 |
MRI, magnetic resonance imaging; CT, computed tomography.
Diagnostic efficacy of MRI in lymphatic metastasis of early cervical cancer in stage II.
| Pathological diagnostic results | |||
|---|---|---|---|
| Grouping | Stage IIa-IIb | Stage non-IIa-IIb | Total |
| IIa-IIb phase by MRI diagnosis | 76 | 14 | 70 |
| Non-IIa-IIb phase by MRI diagnosis | 20 | 50 | 90 |
| Total | 96 | 64 | 160 |
MRI, magnetic resonance imaging.
Comparison of diagnostic efficiency of MRI and CT in lymphatic metastasis of early cervical cancer in stage II.
| Factors | MRI | CT | χ2 value | P-value |
|---|---|---|---|---|
| Sensitivity | 79.17% (76/96) | 62.50% (60/96) | 6.454 | 0.011 |
| Specificity | 78.13% (50/64) | 68.75% (44/64) | 1.442 | 0.230 |
| Diagnostic accordance rate | 78.75% (126/160) | 58.75% (94/160) | 14.890 | <0.001 |
MRI, magnetic resonance imaging; CT, computed tomography.
Diagnostic efficacy of MRI combined with CT in lymphatic metastasis of early cervical cancer in stage I.
| Pathological diagnostic results | |||
|---|---|---|---|
| Grouping | Stage Ia-Ib | Stage non-Ia-Ib | Total |
| Ia-Ib phase by combined diagnosis | 50 | 12 | 62 |
| Non-Ia-Ib phase by combined diagnosis | 14 | 84 | 98 |
| Total | 64 | 96 | 160 |
MRI, magnetic resonance imaging; CT, computed tomography.
Comparison of the diagnostic efficacy between combined diagnosis with MRI or CT alone.
| Factors | Combination | MRI | CT | P-value |
|---|---|---|---|---|
| Stage Ia-Ib | ||||
| Sensitivity | 78.13% (50/64) | 75.00% (54/64) | 62.50% (40/64) | 0.013 |
| Specificity | 87.50% (84/96) | 72.92% (70/96) | 56.25% (54/96) | <0.001 |
| Diagnostic accordance rate | 83.75% (134/160) | 77.50% (124/160) | 58.75% (94/160) | <0.001 |
| Stage IIa-IIb | ||||
| Sensitivity | 91.66% (90/96) | 79.17% (76/96) | 62.50% (60/96) | <0.001 |
| Specificity | 82.81% (53/64) | 78.13% (50/64) | 68.75% (44/64) | 0.161 |
| Diagnostic accordance rate | 88.13% (143/160) | 78.75% (126/160) | 58.75% (94/160) | <0.001 |
MRI, magnetic resonance imaging; CT, computed tomography.
Diagnostic efficacy of CT lymph node metastasis of early cervical cancer in stage I.
| Pathological diagnostic results | |||
|---|---|---|---|
| Grouping | Stage Ia-Ib | Stage non-Ia-Ib | Total |
| Ia-Ib phase by CT diagnosis | 40 | 42 | 82 |
| Non-Ia-Ib phase by CT diagnosis | 24 | 54 | 78 |
| Total | 64 | 96 | 160 |
CT, computed tomography.
Diagnostic efficacy of CT in lymphatic metastasis of early cervical cancer in stage II.
| Pathological diagnostic results | |||
|---|---|---|---|
| Grouping | Stage IIa-IIb | Stage non-IIa-IIb | Total |
| IIa-IIb phase by CT diagnosis | 60 | 20 | 88 |
| Non-IIa-IIb phase by CT diagnosis | 36 | 44 | 72 |
| Total | 96 | 64 | 160 |
CT, computed tomography.
Diagnostic efficacy of MRI combined with CT in lymphatic metastasis of early cervical cancer in stage II.
| Pathological diagnostic results | |||
|---|---|---|---|
| Grouping | Stage IIa-IIb | Stage non-IIa-IIb | Total |
| IIa-IIb phase by combined diagnosis | 90 | 11 | 101 |
| Non-IIa-IIb phase by combined diagnosis | 6 | 53 | 59 |
| Total | 96 | 64 | 160 |
MRI, magnetic resonance imaging; CT, computed tomography.